$ALNY Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALNYLAM PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ALNYLAM PHARMACEUTICALS, INC.. Get notifications about new insider transactions in ALNYLAM PHARMACEUTICALS, INC. for free.
Page: < prev 1 2 3 4 5 6 7 ... 15 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 02 2019 | ALNY | ALNYLAM PHARMACEUT ... | HAMBURG MARGARET A | Director | Option Exercise | A | 72.01 | 9,000 | 648,090 | 9,000 | |
Jul 02 2019 | ALNY | ALNYLAM PHARMACEUT ... | Ausiello Dennis A | Director | Option Exercise | A | 72.01 | 9,000 | 648,090 | 9,000 | |
Jun 07 2019 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | A | 42.22 | 6,250 | 263,875 | 18,750 | |
Jun 07 2019 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | Chief Operating Off ... | Option Exercise | A | 42.22 | 6,250 | 263,875 | 18,750 | |
Jun 07 2019 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | Chief Operating Off ... | Buy | J | 0.00 | 49 | 0 | 357 | 308 to 357 (+15.91 %) |
Jun 07 2019 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | A | 42.22 | 6,250 | 263,875 | 18,750 | |
Jun 07 2019 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Buy | J | 0.00 | 51 | 0 | 467 | 416 to 467 (+12.26 %) |
Jun 07 2019 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Buy | J | 0.00 | 21 | 0 | 416 | 395 to 416 (+5.32 %) |
Jun 07 2019 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Option Exercise | A | 42.22 | 6,250 | 263,875 | 18,750 | |
Jun 07 2019 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Buy | J | 0.00 | 41 | 0 | 375 | 334 to 375 (+12.28 %) |
Jun 07 2019 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Buy | J | 0.00 | 14 | 0 | 334 | 320 to 334 (+4.38 %) |
May 17 2019 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 16.43 | 49,457 | 812,579 | 49,456 | |
May 17 2019 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | J | 0.00 | 61 | 0 | 3,099 | 3 K to 3.1 K (+2.01 %) |
May 17 2019 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 70.00 | 49,457 | 3,461,990 | 189,993 | 239.5 K to 190 K (-20.65 %) |
May 17 2019 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 16.43 | 49,457 | 812,579 | 239,450 | 190 K to 239.5 K (+26.03 %) |
Apr 17 2019 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Option Exercise | M | 22.09 | 15,000 | 331,350 | 0 | |
Apr 17 2019 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Sell | S | 91.40 | 600 | 54,840 | 235,633 | 236.2 K to 235.6 K (-0.25 %) |
Apr 17 2019 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Sell | S | 89.97 | 400 | 35,988 | 236,233 | 236.6 K to 236.2 K (-0.17 %) |
Apr 17 2019 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Sell | S | 89.03 | 2,200 | 195,866 | 236,633 | 238.8 K to 236.6 K (-0.92 %) |
Apr 17 2019 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Sell | S | 87.86 | 11,800 | 1,036,748 | 238,833 | 250.6 K to 238.8 K (-4.71 %) |
Apr 17 2019 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Buy | M | 22.09 | 15,000 | 331,350 | 250,633 | 235.6 K to 250.6 K (+6.37 %) |
Mar 01 2019 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | EVP, Chief Operatin ... | Option Exercise | A | 85.00 | 32,500 | 2,762,500 | 32,500 | |
Mar 01 2019 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Option Exercise | A | 85.00 | 32,500 | 2,762,500 | 32,500 | |
Mar 01 2019 | ALNY | ALNYLAM PHARMACEUT ... | Soni Manmeet Singh | Chief Financial Off ... | Option Exercise | A | 85.00 | 20,000 | 1,700,000 | 20,000 | |
Mar 01 2019 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | A | 85.00 | 32,500 | 2,762,500 | 32,500 | |
Mar 01 2019 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | SVP, GC & Secretary | Option Exercise | A | 85.00 | 25,000 | 2,125,000 | 25,000 | |
Mar 01 2019 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | A | 85.00 | 85,000 | 7,225,000 | 85,000 | |
Jan 11 2019 | ALNY | ALNYLAM PHARMACEUT ... | HAMBURG MARGARET A | Director | Option Exercise | A | 89.16 | 18,000 | 1,604,880 | 18,000 | |
Nov 26 2018 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 21.35 | 98,636 | 2,105,879 | 0 | |
Nov 26 2018 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | J | 0.00 | 17 | 0 | 3,038 | 3 K to 3 K (+0.56 %) |
Nov 26 2018 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Payment of Exercise | F | 72.68 | 59,940 | 4,356,439 | 189,993 | 249.9 K to 190 K (-23.98 %) |
Nov 26 2018 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 21.35 | 98,636 | 2,105,879 | 249,933 | 151.3 K to 249.9 K (+65.19 %) |
Sep 28 2018 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | SVP, GC & Secretary | Option Exercise | A | 42.22 | 6,250 | 263,875 | 12,500 | |
Sep 28 2018 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | SVP, GC & Secretary | Option Exercise | A | 88.95 | 3,500 | 311,325 | 10,500 | |
Sep 28 2018 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | EVP, Chief Operatin ... | Option Exercise | A | 42.22 | 6,250 | 263,875 | 12,500 | |
Sep 28 2018 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | A | 42.22 | 6,250 | 263,875 | 12,500 | |
Sep 28 2018 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | A | 88.95 | 7,500 | 667,125 | 22,500 | |
Sep 28 2018 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | A | 42.22 | 6,250 | 263,875 | 12,500 | |
Sep 28 2018 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | A | 88.95 | 16,250 | 1,445,438 | 48,750 | |
Sep 28 2018 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | A | 42.22 | 1,387 | 58,559 | 2,775 | |
Sep 28 2018 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | A | 88.95 | 1,800 | 160,110 | 5,400 | |
Sep 28 2018 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Option Exercise | A | 42.22 | 6,250 | 263,875 | 12,500 | |
Sep 28 2018 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Option Exercise | A | 88.95 | 10,000 | 889,500 | 30,000 | |
Sep 04 2018 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | EVP, Chief Operatin ... | Sell | S | 120.00 | 2,500 | 300,000 | 1,916 | 4.4 K to 1.9 K (-56.61 %) |
Aug 23 2018 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | A | 88.95 | 16,250 | 1,445,438 | 32,500 | |
Aug 23 2018 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Option Exercise | A | 88.95 | 10,000 | 889,500 | 20,000 | |
Aug 23 2018 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | A | 88.95 | 7,500 | 667,125 | 15,000 | |
Aug 23 2018 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | SVP, GC & Secretary | Option Exercise | A | 88.95 | 3,500 | 311,325 | 7,000 | |
Aug 23 2018 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | A | 88.95 | 1,800 | 160,110 | 3,600 | |
Aug 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Option Exercise | A | 96.45 | 15,875 | 1,531,144 | 47,625 | |
Aug 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Option Exercise | A | 63.00 | 15,000 | 945,000 | 45,000 | |
Aug 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Gift | G | 0.00 | 9,030 | 0 | 9,030 | 0 to 9 K |
Aug 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Buy | J | 0.00 | 29 | 0 | 2,884 | 2.9 K to 2.9 K (+1.02 %) |
Aug 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Buy | J | 0.00 | 28 | 0 | 2,855 | 2.8 K to 2.9 K (+0.99 %) |
Aug 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Buy | J | 0.00 | 17 | 0 | 2,827 | 2.8 K to 2.8 K (+0.60 %) |
Aug 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Gift | G | 0.00 | 9,030 | 0 | 52,938 | 62 K to 52.9 K (-14.57 %) |
Aug 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | A | 96.45 | 11,707 | 1,129,140 | 35,125 | |
Aug 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | A | 63.00 | 10,832 | 682,416 | 32,500 | |
Aug 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Buy | J | 0.00 | 29 | 0 | 395 | 366 to 395 (+7.92 %) |
Aug 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Buy | J | 0.00 | 28 | 0 | 366 | 338 to 366 (+8.28 %) |
Aug 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Payment of Exercise | F | 90.95 | 766 | 69,668 | 12,173 | 12.9 K to 12.2 K (-5.92 %) |
Aug 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Grant | A | 0.00 | 1,724 | 0 | 12,939 | 11.2 K to 12.9 K (+15.37 %) |
Aug 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | A | 96.45 | 25,000 | 2,411,250 | 75,000 | |
Aug 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | A | 63.00 | 25,000 | 1,575,000 | 75,000 | |
Aug 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | EVP, Chief Operatin ... | Option Exercise | A | 77.10 | 25,000 | 1,927,500 | 25,000 | |
Aug 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | EVP, Chief Operatin ... | Buy | J | 0.00 | 38 | 0 | 308 | 270 to 308 (+14.07 %) |
Aug 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | EVP, Chief Operatin ... | Buy | J | 0.00 | 37 | 0 | 270 | 233 to 270 (+15.88 %) |
Aug 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | EVP, Chief Operatin ... | Payment of Exercise | F | 90.95 | 3,084 | 280,490 | 4,416 | 7.5 K to 4.4 K (-41.12 %) |
Aug 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | EVP, Chief Operatin ... | Grant | A | 0.00 | 7,500 | 0 | 7,500 | 0 to 7.5 K |
Aug 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | SVP, GC & Secretary | Option Exercise | A | 96.45 | 1,984 | 191,357 | 5,958 | |
Aug 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | SVP, GC & Secretary | Buy | J | 0.00 | 32 | 0 | 320 | 288 to 320 (+11.11 %) |
Aug 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | SVP, GC & Secretary | Payment of Exercise | F | 90.95 | 605 | 55,025 | 15,258 | 15.9 K to 15.3 K (-3.81 %) |
Aug 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | SVP, GC & Secretary | Grant | A | 0.00 | 1,363 | 0 | 15,863 | 14.5 K to 15.9 K (+9.40 %) |
Aug 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | A | 96.45 | 2,750 | 265,238 | 2,750 | |
Aug 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | A | 63.00 | 1,666 | 104,958 | 1,666 | |
Aug 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Buy | J | 0.00 | 23 | 0 | 276 | 253 to 276 (+9.09 %) |
Aug 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Buy | J | 0.00 | 22 | 0 | 253 | 231 to 253 (+9.52 %) |
Aug 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Buy | J | 0.00 | 5 | 0 | 231 | 226 to 231 (+2.21 %) |
Aug 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Payment of Exercise | F | 90.95 | 449 | 40,837 | 563 | 1 K to 563 (-44.37 %) |
Aug 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Grant | A | 0.00 | 1,012 | 0 | 1,012 | 0 to 1 K |
Aug 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | Soni Manmeet Singh | Chief Financial Off ... | Option Exercise | A | 52.61 | 25,000 | 1,315,250 | 25,000 | |
Aug 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | Soni Manmeet Singh | Chief Financial Off ... | Buy | J | 0.00 | 36 | 0 | 83 | 47 to 83 (+76.60 %) |
Aug 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | Soni Manmeet Singh | Chief Financial Off ... | Buy | J | 0.00 | 28 | 0 | 47 | 19 to 47 (+147.37 %) |
Aug 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | Soni Manmeet Singh | Chief Financial Off ... | Buy | J | 0.00 | 6 | 0 | 19 | 13 to 19 (+46.15 %) |
Aug 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | Soni Manmeet Singh | Chief Financial Off ... | Buy | J | 0.00 | 11 | 0 | 13 | 2 to 13 (+550.00 %) |
Aug 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | Soni Manmeet Singh | Chief Financial Off ... | Buy | J | 0.00 | 2 | 0 | 2 | 0 to 2 |
Jul 27 2018 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 21.35 | 50,000 | 1,067,500 | 98,636 | |
Jul 27 2018 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | J | 0.00 | 31 | 0 | 3,021 | 3 K to 3 K (+1.04 %) |
Jul 27 2018 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | J | 0.00 | 30 | 0 | 2,990 | 3 K to 3 K (+1.01 %) |
Jul 27 2018 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 106.25 | 1,400 | 148,750 | 151,297 | 152.7 K to 151.3 K (-0.92 %) |
Jul 27 2018 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 105.83 | 34,995 | 3,703,521 | 152,697 | 187.7 K to 152.7 K (-18.64 %) |
Jul 27 2018 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 104.83 | 7,758 | 813,271 | 187,692 | 195.5 K to 187.7 K (-3.97 %) |
Jul 27 2018 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 103.69 | 3,847 | 398,895 | 195,450 | 199.3 K to 195.5 K (-1.93 %) |
Jul 27 2018 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 102.51 | 2,000 | 205,020 | 199,297 | 201.3 K to 199.3 K (-0.99 %) |
Jul 27 2018 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 21.35 | 50,000 | 1,067,500 | 201,297 | 151.3 K to 201.3 K (+33.05 %) |
Jun 22 2018 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | SVP, GC & Secretary | Option Exercise | M | 42.22 | 1,563 | 65,990 | 15,626 | |
Jun 22 2018 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | SVP, GC & Secretary | Buy | J | 0.00 | 31 | 0 | 288 | 257 to 288 (+12.06 %) |
Jun 22 2018 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | SVP, GC & Secretary | Sell | S | 105.04 | 1,563 | 164,178 | 14,500 | 16.1 K to 14.5 K (-9.73 %) |
Jun 22 2018 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | SVP, GC & Secretary | Buy | M | 42.22 | 1,563 | 65,990 | 16,063 | 14.5 K to 16.1 K (+10.78 %) |
Jun 22 2018 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Option Exercise | A | 105.26 | 9,000 | 947,340 | 9,000 | |
Jun 22 2018 | ALNY | ALNYLAM PHARMACEUT ... | SCHULMAN AMY W | Director | Option Exercise | A | 105.26 | 9,000 | 947,340 | 9,000 | |
Jun 22 2018 | ALNY | ALNYLAM PHARMACEUT ... | SCHIMMEL PAUL | Director | Option Exercise | A | 105.26 | 9,000 | 947,340 | 9,000 | |
Jun 22 2018 | ALNY | ALNYLAM PHARMACEUT ... | PYOTT DAVID E I | Director | Option Exercise | A | 105.26 | 9,000 | 947,340 | 9,000 | |
Jun 22 2018 | ALNY | ALNYLAM PHARMACEUT ... | PAUL STEVEN M | Director | Option Exercise | A | 105.26 | 9,000 | 947,340 | 9,000 | |
Jun 22 2018 | ALNY | ALNYLAM PHARMACEUT ... | Fanucci Marsha | Director | Option Exercise | A | 105.26 | 9,000 | 947,340 | 9,000 | |
Jun 22 2018 | ALNY | ALNYLAM PHARMACEUT ... | CLARKE JOHN K | Director | Option Exercise | A | 105.26 | 9,000 | 947,340 | 9,000 | |
Jun 22 2018 | ALNY | ALNYLAM PHARMACEUT ... | BONNEY MICHAEL W | Director | Option Exercise | A | 105.26 | 9,000 | 947,340 | 9,000 | |
Jun 22 2018 | ALNY | ALNYLAM PHARMACEUT ... | Ausiello Dennis A | Director | Option Exercise | A | 105.26 | 9,000 | 947,340 | 9,000 | |
Jun 04 2018 | ALNY | ALNYLAM PHARMACEUT ... | Reitan Colleen F | Director | Option Exercise | A | 100.65 | 18,000 | 1,811,700 | 18,000 | |
Jun 04 2018 | ALNY | ALNYLAM PHARMACEUT ... | CLARKE JOHN K | Director | Option Exercise | M | 27.28 | 15,000 | 409,200 | 0 | |
Jun 04 2018 | ALNY | ALNYLAM PHARMACEUT ... | CLARKE JOHN K | Director | Sell | S | 101.97 | 100 | 10,197 | 8,891 | 9 K to 8.9 K (-1.11 %) |
Jun 04 2018 | ALNY | ALNYLAM PHARMACEUT ... | CLARKE JOHN K | Director | Sell | S | 101.37 | 2,100 | 212,877 | 8,991 | 11.1 K to 9 K (-18.93 %) |
Jun 04 2018 | ALNY | ALNYLAM PHARMACEUT ... | CLARKE JOHN K | Director | Sell | S | 100.33 | 10,042 | 1,007,514 | 11,091 | 21.1 K to 11.1 K (-47.52 %) |
Jun 04 2018 | ALNY | ALNYLAM PHARMACEUT ... | CLARKE JOHN K | Director | Sell | S | 99.38 | 2,758 | 274,090 | 21,133 | 23.9 K to 21.1 K (-11.54 %) |
Jun 04 2018 | ALNY | ALNYLAM PHARMACEUT ... | CLARKE JOHN K | Director | Buy | M | 27.28 | 15,000 | 409,200 | 23,891 | 8.9 K to 23.9 K (+168.71 %) |
Mar 28 2018 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | EVP, Chief Operatin ... | Option Exercise | M | 42.22 | 7,221 | 304,871 | 17,779 | |
Mar 28 2018 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | EVP, Chief Operatin ... | Buy | J | 0.00 | 233 | 0 | 233 | 0 to 233 |
Mar 28 2018 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | EVP, Chief Operatin ... | Sell | S | 141.47 | 100 | 14,147 | 0 | 100 to 0 (-100.00 %) |
Mar 28 2018 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | EVP, Chief Operatin ... | Sell | S | 137.78 | 419 | 57,730 | 100 | 519 to 100 (-80.73 %) |
Mar 28 2018 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | EVP, Chief Operatin ... | Sell | S | 137.09 | 2,394 | 328,193 | 519 | 2.9 K to 519 (-82.18 %) |
Mar 28 2018 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | EVP, Chief Operatin ... | Sell | S | 136.00 | 4,308 | 585,888 | 2,913 | 7.2 K to 2.9 K (-59.66 %) |
Mar 28 2018 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | EVP, Chief Operatin ... | Buy | M | 42.22 | 7,221 | 304,871 | 7,221 | 0 to 7.2 K |
Mar 22 2018 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | SVP, GC & Secretary | Option Exercise | M | 42.22 | 1,562 | 65,948 | 17,189 | |
Mar 22 2018 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | SVP, GC & Secretary | Sell | S | 152.79 | 300 | 45,837 | 14,500 | 14.8 K to 14.5 K (-2.03 %) |
Mar 22 2018 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | SVP, GC & Secretary | Sell | S | 151.48 | 200 | 30,296 | 14,800 | 15 K to 14.8 K (-1.33 %) |
Mar 22 2018 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | SVP, GC & Secretary | Sell | S | 149.97 | 500 | 74,985 | 15,000 | 15.5 K to 15 K (-3.23 %) |
Mar 22 2018 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | SVP, GC & Secretary | Sell | S | 147.79 | 462 | 68,279 | 15,500 | 16 K to 15.5 K (-2.89 %) |
Mar 22 2018 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | SVP, GC & Secretary | Sell | S | 146.36 | 100 | 14,636 | 15,962 | 16.1 K to 16 K (-0.62 %) |
Mar 22 2018 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | SVP, GC & Secretary | Buy | M | 42.22 | 1,562 | 65,948 | 16,062 | 14.5 K to 16.1 K (+10.77 %) |
Mar 16 2018 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | M | 18.66 | 44,641 | 833,001 | 0 | |
Mar 16 2018 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | M | 16.43 | 38,913 | 639,341 | 0 | |
Mar 16 2018 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | M | 7.10 | 5,000 | 35,500 | 0 | |
Mar 16 2018 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Sell | S | 145.27 | 6,380 | 926,823 | 11,215 | 17.6 K to 11.2 K (-36.26 %) |
Mar 16 2018 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Sell | S | 144.53 | 20,172 | 2,915,459 | 17,595 | 37.8 K to 17.6 K (-53.41 %) |
Mar 16 2018 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Sell | S | 143.46 | 19,213 | 2,756,297 | 37,767 | 57 K to 37.8 K (-33.72 %) |
Mar 16 2018 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Sell | S | 142.57 | 21,336 | 3,041,874 | 56,980 | 78.3 K to 57 K (-27.24 %) |
Mar 16 2018 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Sell | S | 141.69 | 15,000 | 2,125,350 | 78,316 | 93.3 K to 78.3 K (-16.07 %) |
Mar 16 2018 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Sell | S | 140.45 | 6,453 | 906,324 | 93,316 | 99.8 K to 93.3 K (-6.47 %) |
Mar 16 2018 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Buy | M | 7.10 | 5,000 | 35,500 | 99,769 | 94.8 K to 99.8 K (+5.28 %) |
Mar 16 2018 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Buy | M | 16.43 | 38,913 | 639,341 | 94,769 | 55.9 K to 94.8 K (+69.67 %) |
Mar 16 2018 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Buy | M | 18.66 | 44,641 | 833,001 | 55,856 | 11.2 K to 55.9 K (+398.05 %) |
Mar 16 2018 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Sell | S | 145.41 | 1,300 | 189,033 | 61,968 | 63.3 K to 62 K (-2.05 %) |
Mar 16 2018 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Sell | S | 144.67 | 9,165 | 1,325,901 | 63,268 | 72.4 K to 63.3 K (-12.65 %) |
Mar 16 2018 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Sell | S | 143.58 | 8,644 | 1,241,106 | 72,433 | 81.1 K to 72.4 K (-10.66 %) |
Mar 16 2018 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Sell | S | 142.68 | 9,217 | 1,315,082 | 81,077 | 90.3 K to 81.1 K (-10.21 %) |
Mar 16 2018 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Sell | S | 141.74 | 7,250 | 1,027,615 | 90,294 | 97.5 K to 90.3 K (-7.43 %) |
Mar 16 2018 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Sell | S | 140.43 | 2,884 | 405,000 | 97,544 | 100.4 K to 97.5 K (-2.87 %) |
Mar 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | SVP, GC & Secretary | Option Exercise | M | 77.40 | 10,000 | 774,000 | 72,000 | |
Mar 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | SVP, GC & Secretary | Option Exercise | M | 77.40 | 10,000 | 774,000 | 82,000 | |
Mar 14 2018 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | SVP, GC & Secretary | Sell | S | 150.00 | 10,000 | 1,500,000 | 14,500 | 24.5 K to 14.5 K (-40.82 %) |